Clinical characteristics of HIV-infected patients with and those without hepatotoxicity after receiving trimethoprim/sulfamethoxazole for treatment of <i>Pneumocystis jirovecii</i> pneumonia.

Note: Data represent the median value (range) for continuous variables and the number of cases (%) for categorical variables. N indicates the number of patients being tested. Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; BMI, body-mass index; HBsAg, hepatitis B virus surface antigen; HCV, hepatitis C virus; IDU, injecting drug user; LDH, lactate dehydrogenase; TMP/SMX, trimethoprim/sulfamethoxazole; NAT1, N-acetyltransferase-1; NAT2, N-acetyltransferase-2. Clinical characteristics of HIV-infected patients with and those without hepatotoxicity after receiving trimethoprim/sulfamethoxazole for treatment of Pneumocystis jirovecii pneumonia.